Kewaunee Scientific stock analysis
Kewaunee Scientific (KEW) Stock Price & Analysis
KEW Stock Chart & Stats
- Day’s Range
- EUR 29.80 - EUR 29.80
- 52-Week Range
- EUR 28.00 - EUR 36.40
- Previous Close
- EUR 30.20
- Volume
- N/A
- Average Volume (3M)
- 0
- Market Cap
- EUR 87.43M
- Enterprise Value
- EUR 151.76M
- Total Cash (Recent Filing)
- EUR 8.25M
- Total Debt (Recent Filing)
- EUR 55.47M
- Price to Earnings (P/E)
- 12.3
- Beta
- 0.77
- Next Earnings
- Dec 16, 2026 (Est.)
- EPS Estimate
- N/A
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
Bulls Say, Bears Say
Bulls Say
Sustained Gross-margin Improvement
Gross margin has remained near 28–29% after the earlier turnaround, indicating that improved pricing, product mix, or cost control has persisted rather than being confined to one period. This provides a stronger base for earnings and supports reinvestment in the integrated laboratory-solutions platform.
Scaled Growth Platform
The near-doubling of revenue over five fiscal years, alongside higher EBITDA, demonstrates that Kewaunee has materially expanded its operating platform. Its differentiated U.S. manufacturing footprint and Lab Products Group investments may support continued scale and improve its ability to pursue larger laboratory projects.
Nycom Integration Opportunity
Acquiring a major laboratory dealer could broaden Kewaunee’s access to customers and connect design and project-delivery capabilities more closely with its manufacturing operations. If integration is executed effectively, the combination may strengthen solution breadth, channel control, and project capture over the coming quarters.
Bears Say
Slowing Demand And Margin Compression
Negative trailing revenue growth combined with net margin compression indicates that the earlier earnings improvement has cooled. Softer project activity or timing can reduce operating leverage, while a thinner profit buffer leaves less room to absorb execution challenges and makes sustainable earnings growth more difficult.
Weaker Cash-flow Momentum
Positive trailing operating and free cash flow remain constructive, but the material decline from FY2026 signals weaker cash conversion momentum. Because operating cash flow is described as modest relative to earnings, working-capital swings or execution friction could constrain internally funded growth and capital flexibility.
Rising Leverage
Although leverage remains below one times equity and is substantially improved from FY2022, the recent increase makes the capital structure more debt-reliant. Higher obligations can reduce flexibility for investment or acquisitions and increase the importance of consistent cash generation during a softer revenue period.
Kewaunee Scientific News
KEW FAQ
What was Kewaunee Scientific’s price range in the past 12 months?
What is Kewaunee Scientific’s market cap?
When is Kewaunee Scientific’s upcoming earnings report date?
How were Kewaunee Scientific’s earnings last quarter?
Is Kewaunee Scientific overvalued?
Does Kewaunee Scientific pay dividends?
What is Kewaunee Scientific’s EPS estimate?
How many shares outstanding does Kewaunee Scientific have?
What happened to Kewaunee Scientific’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Kewaunee Scientific?
What is the TipRanks Smart Score and how is it calculated?
Kewaunee Scientific Stock Smart Score
Company Description
Kewaunee Scientific
Kewaunee Scientific Corporation, established in 1906 and based in Statesville, North Carolina, specializes in providing custom furniture and infrastructure systems for scientific, medical, and technical settings. The company manages its operations through distinct domestic and international divisions. Its extensive product line features diverse furniture options crafted from steel, wood, and laminate, along with specialized equipment like fume hoods, biological safety cabinets, laminar flow systems, and ductless hoods. Kewaunee also offers versatile modular and column systems, mobile workstations, carts, durable epoxy resin worksurfaces, sinks, and various accessories, all supported by comprehensive design assistance. These solutions serve a broad client base: Laboratory products are essential for chemistry, physics, biology, and other general science research conducted in the pharmaceutical, biotechnology, industrial, chemical, commercial, educational, governmental, and healthcare industries. Technical products are utilized in facilities manufacturing computers and light electronics, as well as by those requiring furniture for computer and networking setups. Laminate casework applications extend to educational, healthcare, and industrial environments. The corporation primarily distributes its offerings through a network of independent dealers, its own subsidiary companies, and a major national distributor.
- Sector
- Consumercyclical
- Industry
- Furnishings, Fixtures & Appliances
- CEO
- Thomas David Hull
- Employees
- 1,231
- Website
- www.kewaunee.com
- Address
- 2700 West Front Street, Statesville, NC, 28677-2927, US
Kewaunee Scientific (KEW) Earnings & Revenues
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 12 | 5 | 5 |
| Technical Analysis | 4 | 5 | 1 |
| Moving Averages | 8 | 0 | 4 |







